Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
8 trials since 2013, 2 ongoing, by the sponsor of the products; see every authorized trial
A randomized, double-blind, placebo-controlled, 52-week study to assess the efficacy and safety of etrasimod in…Dec 22, 2020 · Closed · Etrasimod (APD334)
Phase 2, a multicenter, randomized, double-blind, placebo-controlled, 24-week study, with a 28-week open-label…Mar 13, 2020 · Closed · Etrasimod
A multicenter, randomized, double-blind, parallel-group study to assess the efficacy and safety of oral etrasimod as…Feb 20, 2020 · Closed · Etrasimod (APD334)
A multicenter, randomized, double-blinded, placebo-controlled 16-week study (with a 52-week open-label extension) to…Jul 18, 2019 · Closed · Etrasimod (APD334)
A phase 3, randomized, double-blind, placebo-controlled, 12-week study to assess the efficacy and safety of etrasimod…May 23, 2019 · Ongoing · Etrasimod (APD334)
An open-label extension study of etrasimod in subjects with moderately to severely active ulcerative colitisMar 13, 2019 · Ongoing · Etrasimod (APD334)
A phase 3, randomized, double-blind, placebo-controlled, 52-week study to assess the efficacy and safety of etrasimod…Mar 13, 2019 · Closed · Etrasimod (APD334)
A phase 2, randomized, double-blind, placebo-controlled, parallel group, multi-center study to investigate the safety…Nov 12, 2015 · Closed · APD334
Payments to doctors (Open Payments)
What this company reported paying US doctors and teaching hospitals each year, $9.2M of it for research; see every company
$6.6M20222022Paid$6.6M
$2.0M20232023Paid$2.0Mvs 2022−$4.6M
$607K20242024Paid$607Kvs 2023−$1.4M
$89K20252025Paid$89Kvs 2024−$518K
Orphan designations (FDA)
One designation since 1983, 0 approved for the designated use, matched by the sponsor's name; see all orphan designations
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.